U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
134431134431Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic SyndromesTerminatedNo Results AvailableMyelodysplastic SyndromesDrug: ATO + Ascorbic acidhttps://ClinicalTrials.gov/show/NCT00803530
134432134432Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous ChorioretinopathyCompletedHas ResultsCentral Serous Chorioretinopathyhttps://ClinicalTrials.gov/show/NCT00803517
134433134433Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle GlaucomaCompletedNo Results AvailablePrimary Open Angle GlaucomaProcedure: ocular blood flow measurementhttps://ClinicalTrials.gov/show/NCT00803504
134434134434Health Related Quality of Life After a Self-promoting Learning Program for People With Rheumatic DiseasesActive, not recruitingNo Results AvailableRheumatic DiseasesOther: Problem based learning|Other: Traditional rheumatology care.https://ClinicalTrials.gov/show/NCT00803491
134435134435The Effect of Hinge Position and Hinge Width on Corneal Sensation and Dry Eye After IntraLase LASIK ProcedureRecruitingNo Results AvailableMyopiaProcedure: LASIKhttps://ClinicalTrials.gov/show/NCT00803478
134436134436Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical CreamsCompletedNo Results AvailableHealthyDrug: Fluticasone Propionate 0.05% Cream-Reference Product|Drug: Fluticasone Propionate 0.05% Cream-Test producthttps://ClinicalTrials.gov/show/NCT00803465
134437134437Lipids of the Human Tear Film and Their Effect on Tear StabilityRecruitingNo Results AvailableBlepharitisDrug: doxycycline|Drug: essential fatty acid|Drug: azithromycinhttps://ClinicalTrials.gov/show/NCT00803452
134438134438Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical FoamsCompletedNo Results AvailableHealthyDrug: Clobetasol Propionate 0.05% Foam-Reference Product|Drug: Clobetasol Propionate 0.05% Foam-Test producthttps://ClinicalTrials.gov/show/NCT00803439
134439134439Ultrasound Guided Popliteal Fossa Block. Does Blockade Distal to Sciatic Nerve Bifurcation Speed Onset Time? A Prospective, Randomized TrialCompletedNo Results AvailableAnkle/Foot Surgery.Procedure: Sciatic nerve blockade for ankle/foot surgeryhttps://ClinicalTrials.gov/show/NCT00803426
134440134440Effect of Back School and Supervised Walking in Sedentary Women With Chronic Low Back PainCompletedHas ResultsChronic Low Back PainBehavioral: Back School Intervention|Behavioral: Supervised Walking Intervention|Behavioral: Back School and Walking|Behavioral: Control Grouphttps://ClinicalTrials.gov/show/NCT00803413
134441134441Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder TreatmentCompletedHas ResultsPanic DisorderDrug: Alprazolam|Drug: Alprazolam + Aerobic exercisehttps://ClinicalTrials.gov/show/NCT00803400
134442134442Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without PreservativeCompletedNo Results AvailableOcular Dryness|Ocular Irritation|Open-Angle Glaucoma|Ocular HypertensionDrug: Travaprost without BAC (Travatan Z)https://ClinicalTrials.gov/show/NCT00803387
134443134443Combination of Anti-CD137 & Ipilimumab in Patients With MelanomaWithdrawnNo Results AvailableMelanomaDrug: AntiCD137|Drug: AntiCD137|Drug: AntiCD137|Drug: AntiCD137|Drug: AntiCD137|Drug: Ipilimumabhttps://ClinicalTrials.gov/show/NCT00803374
134444134444Duloxetine for the Treatment of Generalized Anxiety DisorderCompletedHas ResultsGeneralized Anxiety DisorderDrug: Duloxetine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00803361
134445134445Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee ArthroplastyCompletedNo Results AvailableKnee ArthroplastyDrug: Bolus of 0.2% ropivicaine 20 mls followed by 0.2% ropivicaine at an infusion rate of 5mls/hr until 0600 on postoperative day 2|Drug: Bolus of 0.2% ropivicaine 20 mls followed by 0.1% ropivicaine at an infusion rate of 10mls/hr until 0600 on post-operative day 2|Drug: Saline controlhttps://ClinicalTrials.gov/show/NCT00803348
134446134446The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ ProlapseCompletedNo Results AvailablePelvic Organ Prolapse|Vaginal AtrophyDrug: Vaginal conjugated estrogen cream 0.5gm|Drug: Vaginal conjugated estrogen cream 1.0gmhttps://ClinicalTrials.gov/show/NCT00803335
134447134447Improving Community Based Tuberculosis Care in EthiopiaCompletedNo Results AvailablePulmonary Tuberculosishttps://ClinicalTrials.gov/show/NCT00803322
134448134448Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 PatientsTerminatedNo Results AvailableHepatitis C, ChronicDrug: pegylated interferon alpha-2b|Drug: Ribavirin|Drug: pegylated Interferon alpha-2b|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00803309
134449134449Incretin Effect in Lean and Obese SubjectsCompletedNo Results AvailableIncretin Effect|Insulin Resistance|Type 2 DiabetesOther: Oral glucose tolerance test (OGTT)|Other: Isoglycemic intravenous glucose infusionhttps://ClinicalTrials.gov/show/NCT00803296
134450134450A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer PainTerminatedHas ResultsCancer PainDrug: Hydromprphone Hydrochloride (HCl) OROS|Drug: Morphine Sustain Release (SR)https://ClinicalTrials.gov/show/NCT00803283
134451134451Mixed Incontinence: Medical Or Surgical Approach?TerminatedHas ResultsUrinary IncontinenceDrug: Non-Surgical Intervention|Procedure: Surgicalhttps://ClinicalTrials.gov/show/NCT00803270
134452134452Effect of Lumbrical Stretching on Carpal Tunnel SyndromeCompletedNo Results AvailableCarpal Tunnel SyndromeOther: Lumbrical splint and Lumbrical exerciseshttps://ClinicalTrials.gov/show/NCT00803257
134453134453Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis (With or Without Asthma)CompletedNo Results AvailablePrimary DiseaseBiological: 300 IR grass pollen tablet|Biological: Placebo tablethttps://ClinicalTrials.gov/show/NCT00803244
134454134454Follow-up Data of Patients Treated With XIGRIS® in FranceCompletedNo Results AvailableSepsishttps://ClinicalTrials.gov/show/NCT00803231
134455134455Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical OintmentsCompletedNo Results AvailableHealthyDrug: Fluticasone Propionate 0.005% Ointment-Reference Product|Drug: Fluticasone Propionate 0.005% Ointment-Test producthttps://ClinicalTrials.gov/show/NCT00803218
134456134456Study of Ataluren (PTC124â„¢) in Cystic FibrosisCompletedNo Results AvailableCystic FibrosisDrug: Ataluren (PTC124)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00803205
134457134457Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed ConditionsCompletedNo Results AvailableBioavailabilityDrug: Famotidine Tablets, 40 mghttps://ClinicalTrials.gov/show/NCT00803192
134458134458Growth Hormone Therapy for Wasting in Cystic FibrosisTerminatedHas ResultsCystic FibrosisDrug: Nutropin AQhttps://ClinicalTrials.gov/show/NCT00803179
134459134459Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical CreamsCompletedNo Results AvailableHealthyDrug: Halobetasol Propionate 0.05% Cream-Reference Product|Drug: Halobetasol Propionate 0.05% Cream-Test product 1|Drug: Halobetasol Propionate 0.05% Cream-Test Product 2https://ClinicalTrials.gov/show/NCT00803166
134460134460PASCAL: Safety and Complications, Experience After 1301 Consecutive CasesCompletedNo Results AvailableBruch Rupture|Choroidal DetachmentProcedure: Panretinal Photocoagulation [Pattern Scan Laser (PASCAL) system]https://ClinicalTrials.gov/show/NCT00803153

* Görseller ve İçerik tekif hakkına sahip olabilir